...
机译:STCF3-ZNF384 TCF3-ZNF384 - 阳性急性淋巴细胞白血病的末期复发案
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of NursingSt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
Department of Pediatric Hematology and OncologyJapanese Red Cross Narita HospitalNarita Japan;
Department of Pediatric Hematology and Oncology ResearchNational Research Institute for Child;
Department of Pediatric Hematology and Oncology ResearchNational Research Institute for Child;
Department of HematologySt. Luke's International HospitalTokyo Japan;
Department of PediatricsSt. Luke's International HospitalTokyo Japan;
机译:STCF3-ZNF384 TCF3-ZNF384 - 阳性急性淋巴细胞白血病的末期复发案
机译:ZNF384基因重排的小儿急性淋巴细胞白血病的频率和预后,包括一种新的易位导致ARID1B / ZNF384基因融合
机译:小儿急性淋巴细胞白血病,T(1; 19)/ TCF3-PBX1 TCF3-PBX1
机译:利用人工神经网络优化急性淋巴细胞白血病和急性髓性白血病样品的分类
机译:复发性急性淋巴细胞白血病中NT5C2突变的机制和治疗靶点
机译:根据AIEOP-BFM协议治疗的ABL级融合阳性B细胞急性淋巴细胞白血病患儿的复发和与治疗相关的事件同样可导致不良预后
机译:纯合转录因子3基因(TCF3)突变与严重的低磷蛋白血症和B细胞急性淋巴细胞白血病有关